Born in Meran / Italy, Andreas Premstaller studied Chemistry at the Leopold-Franzens-University in Innsbruck, Austria. There, he worked for four years in Professor Christian Huber's group at the Institute of Analytical Chemistry and Radiochemistry. His research focused on novel techniques for the separation of biomolecules and the hyphenation of these methods to mass spectrometry for the analysis of oligonucleotides, DNA and proteins. After obtaining his Ph.D. in 2000, Dr. Premstaller extended his work in the field of mass spectrometry and miniaturized separation systems for biomolecules during a Postdoctoral fellowship at the Stanford Genome Technology Center in Palo Alto, CA, in Peter Oefner's group (Erwin Schrödinger Fellowship of the Austrian Science Fund).
Andreas Premstaller joined the analytical development group of Sandoz Biopharmaceuticals in Kundl, Austria in 2002. As Head of Analytical Characterization of Biopharmaceutical Operations (BPO), he is now responsible for the characterization of recombinant protein products for the Novartis/Sandoz group. Dr. Premstaller is a member of the American Society for Mass Spectrometry.